False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral center.
Semin Arthritis Rheum
; 56: 152052, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35753143
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Raynaud Disease
/
Scleroderma, Localized
/
Scleroderma, Systemic
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Semin Arthritis Rheum
Year:
2022
Document type:
Article
Affiliation country:
United States